Your Biotech Company Has Security Tools. Investors Want Proof Someone Will Respond
The most dangerous cybersecurity assumption in biotech is that security technology running 24/7 creates 24/7 protection.
It does not.
An endpoint platform can generate an alert at 2:13 a.m. A SIEM can correlate suspicious activity. A cloud platform can record a privileged login from an unusual location.
None of those tools decides whether the activity threatens research, intellectual property, clinical data, or business continuity.
Protection begins when a qualified person investigates.
For many biotech companies under $100 million in revenue, that responsibility falls to a Director of IT, a small infrastructure team, or an employee who is “on call” while also responsible for user support, vendors, cloud systems, compliance, projects, and executive requests.
Leadership may describe this as a lean operating model.
Investors may see it as a single point of failure.
Your Internal Team Is Not the Problem
The internal team is often blamed for slow response, incomplete reporting, or inconsistent monitoring.
That diagnosis is usually wrong.
The operating model is the problem.
A small team cannot deliver normal business support, manage projects, secure the environment, maintain compliance evidence, coordinate vendors, and remain continuously alert overnight without eventually missing something.
Adding an alerting application does not create more human capacity.
It creates more work.
The false belief is that security monitoring can be added to someone’s existing responsibilities because serious incidents are rare. But a security operation is not designed around how often a crisis occurs.
It is designed around how quickly the company must act when one does.
HHS cybersecurity guidance for the healthcare and public-health sector identifies real-time monitoring, 24/7 coverage, integrated response plans, and continuous improvement as important elements of security operations and incident response.
The lesson for biotech leadership is direct:
Continuous technology without continuous investigation is incomplete coverage.
Walk Through the 2:13 A.M. Alert
Imagine a privileged account authenticates from an unfamiliar location after midnight.
Minutes later, the account accesses a research repository and begins downloading an unusual volume of files.
The alert reaches an employee’s phone.
Now answer the questions that matter:
Does the employee wake up?
Can that person validate the login?
Can they review identity, endpoint, cloud, and network evidence?
Do they know whether the account belongs to a traveling researcher, a contractor, or an attacker?
Can they suspend the account without disrupting active research?
Who authorizes containment?
Who informs the CEO or legal counsel?
How is the evidence preserved?
A company does not have after-hours response because somebody receives an email.
It has after-hours response when trained personnel are accountable for investigation, escalation, and action within defined timeframes.
Delay Changes the Business Impact
The first alert may represent a manageable event: a compromised password, a single infected endpoint, or suspicious access that could be contained quickly.
Leave it uninvestigated, and the business problem changes.
An attacker may obtain additional access, identify higher-value systems, steal proprietary information, disrupt laboratory operations, encrypt systems, or compromise data needed for research and regulatory work.
The internal team then arrives in the morning facing a wider incident, fewer containment options, and harder questions from leadership.
NIST Cybersecurity Framework 2.0 treats Detect, Respond, and Recover as connected outcomes, alongside governance, identification, and protection. Detection without response is not a completed security function.
This is where valuation and investor confidence enter the discussion.
The weakness is not simply that an alert was missed. It is that management cannot demonstrate a reliable process for protecting the systems and information on which future value depends.
“Rapid Response” Is Often Meaningless
Security providers and internal teams frequently use phrases such as “immediate notification” or “rapid response.”
Those phrases sound reassuring until leadership asks what they mean.
Did an automated system open a ticket?
Did a human acknowledge the alert?
Did an analyst begin investigating?
Was the activity confirmed as malicious?
Was the account disabled or the endpoint isolated?
Each is a different milestone.
A credible operating model defines severity levels, acknowledgement targets, investigation expectations, escalation thresholds, and containment authority.
Executives should insist on metrics showing:
- Time from alert creation to human review.
- Time from review to active investigation.
- Time from confirmed threat to escalation.
- Time from authorization to containment.
- Percentage of high-severity alerts handled within the agreed commitment.
- Number of recurring detections that remain unresolved.
These are not vanity metrics.
They reveal whether the company can act under pressure.
Managed Security Should Strengthen the Internal Team
Managed security services should not be positioned as a cheap substitute for internal leadership.
The strongest model is often co-managed.
The internal Director of IT or CISO retains strategy, business context, risk decisions, and executive communication. The managed security team provides continuous monitoring, deeper investigation capacity, documented escalation, specialized experience, and coverage when internal personnel are unavailable.
That division of responsibility reduces dependency on one person without removing accountability from the company.
A provider serving biotech must also understand that containment decisions can affect:
- Research workflows.
- Laboratory systems.
- External collaborators.
- Regulated information.
- Cloud research platforms.
- Time-sensitive experiments.
- Clinical or regulatory activity.
Automatically isolating every system may create unnecessary disruption. Waiting for perfect certainty may allow the incident to spread.
The response model must balance security urgency with business context.
That requires experience, documented authority, and communication procedures established before the incident occurs.
Decision Criteria That Expose Weak Providers
Before relying on a managed security partner, ask:
Who monitors the environment overnight?
Are qualified analysts actively investigating, or is the provider simply forwarding alerts?
Which identity, endpoint, cloud, firewall, email, and application data sources are reviewed?
What events trigger human investigation?
What acknowledgement and investigation times are guaranteed?
Can the provider contain activity, or only recommend action?
How are internal leaders reached after hours?
What happens when those leaders do not respond?
How are incidents documented for executives, insurers, investors, legal counsel, and future diligence reviews?
How often are escalation and containment procedures tested?
A provider should be able to answer these questions without hiding behind a dashboard demonstration or a list of technology partners.
Growth Makes the Gap More Dangerous
The security model that worked with 25 employees may fail after the company adds researchers, cloud platforms, external partners, clinical programs, or new locations.
Growth creates more identities, more data, more vendors, more access paths, and more operational dependencies.
Security capacity must grow with that exposure.
The question is not whether your internal team is dedicated.
It probably is.
The question is whether dedication can replace qualified, accountable, after-hours investigation.
When investors or strategic partners examine the operating model, “our IT director gets the alerts” will not sound like security maturity.
It will sound like a risk the company has not yet decided to manage.
About Single Point of Contact
Single Point of Contact is an experienced MSP in the biotech industry and is a valuable partner, providing specialized knowledge in implementing robust backup strategies and ensuring network security and stability. With deep understanding of regulatory requirements such as HIPAA and FDA’s 21 CFR Part 11, Single Point of Contact safeguards sensitive research data, clinical trial information, and intellectual property. They offer tailored solutions, including automated backups, real-time monitoring, and disaster recovery plans, minimizing downtime and data loss. By managing security protocols, they protect against cyber threats, allowing biotech companies to focus on innovation while ensuring compliance and uninterrupted operations. This expertise enhances productivity and reduces risk. Contact us today to discover more about how we can help your biotech firm with DR, backup and security.
Biotech Podcast
On this podcast, we discuss data recovery. This episode explores the significant challenges biotech firms face in developing effective data recovery strategies. Topics include the importance of regular testing, rapid restoration capabilities, and the risks of inadequate planning. It highlights how speed and efficiency are crucial to uninterrupted operations, regulatory compliance, and maintaining trust in a data-driven industry. Tune in to the discussion.
Biotech YouTube
Subscribe to our YouTube channel. On a recent episode,” The Delay That Destroys Biotech”, Most biotech breaches aren’t discovered for months. And by the time they are, the damage is already done. In this episode, we break down what really happens during that silent window and why detection time, not prevention, defines your risk. If you can’t see it early, you can’t control it.
